Clorox Company (The) (CLX) Stake Decreased by First Citizens Bank & Trust Co.

First Citizens Bank & Trust Co. lowered its stake in shares of Clorox Company (The) (NYSE:CLX) by 2.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,682 shares of the company’s stock after selling 74 shares during the period. First Citizens Bank & Trust Co.’s holdings in Clorox Company (The) were worth $491,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of CLX. American Beacon Advisors Inc. acquired a new position in shares of Clorox Company (The) during the first quarter valued at $104,000. Quadrant Capital Group LLC raised its position in shares of Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock valued at $106,000 after buying an additional 158 shares during the last quarter. Valley National Advisers Inc. raised its position in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after buying an additional 5 shares during the last quarter. Blue Chip Partners Inc. raised its position in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares during the last quarter. Finally, Zions Bancorporation raised its position in shares of Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock valued at $134,000 after buying an additional 53 shares during the last quarter. 69.83% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Clorox Company (NYSE:CLX) traded up 0.5012% during trading on Friday, reaching $137.8575. 313,621 shares of the company were exchanged. The company has a 50 day moving average price of $133.42 and a 200-day moving average price of $134.00. Clorox Company has a one year low of $111.24 and a one year high of $141.76. The stock has a market capitalization of $17.79 billion, a price-to-earnings ratio of 25.8402 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. During the same quarter in the prior year, the business earned $1.30 EPS. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. Equities analysts predict that Clorox Company will post $5.67 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This story was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at https://stocknewstimes.com/2017/08/18/clorox-company-the-clx-stake-decreased-by-first-citizens-bank-trust-co-updated-updated.html.

Several brokerages recently weighed in on CLX. Jefferies Group LLC reaffirmed a “hold” rating and set a $137.00 price objective (up previously from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Zacks Investment Research lowered shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. BidaskClub lowered shares of Clorox Company (The) from a “sell” rating to a “strong sell” rating in a research report on Monday, July 24th. Finally, Barclays PLC reissued an “equal weight” rating and issued a $136.00 price target (down previously from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $129.05.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply